In this study, the stereoselective
bioactivity, acute toxicity,
and environmental fate for famoxadone enantiomers were reported for
the first time. Five representative pathogens (e.g., Alternaria solani) were used to investigate enantioselective
activity, and three non-target organisms (e.g., Selenastrum
bibraianum) were used to evaluate acute toxicity. S-Famoxadone was 3.00–6.59 times more effective than R-famoxadone. R-Famoxadone also showed
1.80–6.40 times more toxicity than S-famoxadone
toward S. bibraianum and Daphnia magna. The toxicity of R-famoxadone was 100 times more toxic than S-famoxadone
toward Danio rerio. Under aerobic conditions,
the half-life (t
1/2) for famoxadone enantiomer
degradation was 46.2–126 days in different soils and the enantiomeric
fraction (EF) ranged from 0.435 to 0.470 after 120 days. R-Famoxadone preferentially degraded in three soils, resulting in
an enrichment of S-famoxadone. Under anaerobic conditions, t
1/2 of famoxadone enantiomers was 62.4–147
days in different soils and the EF ranged from 0.489 to 0.495, indicating
that famoxadone enantiomers were not enantioselective. This study
will be useful for the environmental and health risk assessments for
famoxadone enantiomers.